跳至主要内容
临床试验/NCT00415766
NCT00415766Unknown4 期

Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders

Eugonia1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
150
试验地点
1
主要终点
Percentage of mature oocytes

研究概览

简要总结

The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.

详细描述

Urinary human chorionic gonadotrophin (u-hCG) has been widely used to induce final oocyte maturation and to trigger ovulation in assisted conception. Recombinant technology has allowed the production of r-hCG inj which all urinary contaminants are absent. Hence, this would allow the safe subcutaneous administration of a compound with less batch-to-batch variation. This study will investigate the effectiveness of the recombinant hCG compared to the currently used urinary hCG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • At least 14 follicles >11mm on the day of triggering final oocyte maturation
  • Pretreated with GnRH antagonist protocol

排除标准

  • Poor responders
  • Women with 25 or more follicles on the day of trigger

研究组 & 干预措施

rHCG 250 ug

Active Comparator

Injection of 250 ug Ovitrelle to trigger final oocyte maturation

干预措施: rHCG 250ug (Drug)

uHCG 5000 IU

Active Comparator

Injection of 5000 IU Pregnyl to trigger final oocyte maturation

干预措施: uHCG 5000 IU (Drug)

uHCG 7500 IU

Active Comparator

Injection of 7500 IU Pregnyl to trigger final oocyte maturation

干预措施: uHCG 7500 IU (Drug)

结局指标

主要结局

Percentage of mature oocytes

时间窗: Day of oocyte retrieval (Day 0)

Percentage MII/COCs

次要结局

  • Positive test per embryo transfer(15 days post oocyte retrieval)
  • Clinical pregnancy per embryo transfer(7 weeks of gestation)
  • Ongoing pregnancy per embryo transfer(12 weeks of gestation)
  • Level of serum hCG on day of oocyte retrieval(Day of oocyte retrieval)
  • Number of oocytes (COC) retrieved(Day of oocyte retrieval)
  • Number of mature oocytes (MII)(Day of oocyte retrieval)
  • Oocyte retrieval rate(Day of oocyte retrieval (Day 0))
  • Incidence of severe early OHSS(up to Day 5 post oocyte retrieval)

研究者

发起方
Eugonia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparison Between Recombinant Versus Urinary hCG... | 临床试验